141 related articles for article (PubMed ID: 17520224)
21. Combination Therapy with Empagliflozin and Insulin Results in Successful Glycemic Control: A Case Report of Uncontrolled Diabetes Caused by Autoimmune Pancreatitis and Subsequent Steroid Treatment.
Kishimoto M; Yamaoki K; Adachi M
Case Rep Endocrinol; 2019; 2019():9415347. PubMed ID: 30895163
[TBL] [Abstract][Full Text] [Related]
22. Clinical practice guidelines for IgG4-related sclerosing cholangitis.
Kamisawa T; Nakazawa T; Tazuma S; Zen Y; Tanaka A; Ohara H; Muraki T; Inui K; Inoue D; Nishino T; Naitoh I; Itoi T; Notohara K; Kanno A; Kubota K; Hirano K; Isayama H; Shimizu K; Tsuyuguchi T; Shimosegawa T; Kawa S; Chiba T; Okazaki K; Takikawa H; Kimura W; Unno M; Yoshida M
J Hepatobiliary Pancreat Sci; 2019 Jan; 26(1):9-42. PubMed ID: 30575336
[TBL] [Abstract][Full Text] [Related]
23. Current perspectives on autoimmune pancreatitis and IgG4-related disease.
Okazaki K; Uchida K
Proc Jpn Acad Ser B Phys Biol Sci; 2018; 94(10):412-427. PubMed ID: 30541967
[TBL] [Abstract][Full Text] [Related]
24. Impact of hyperglycemia on autoimmune pancreatitis and regulatory T-cells.
Müller-Graff FT; Fitzner B; Jaster R; Vollmar B; Zechner D
World J Gastroenterol; 2018 Jul; 24(28):3120-3129. PubMed ID: 30065558
[TBL] [Abstract][Full Text] [Related]
25. Prognosis of type 1 autoimmune pancreatitis after corticosteroid therapy-induced remission in terms of relapse and diabetes mellitus.
Miyazawa M; Takatori H; Shimakami T; Kawaguchi K; Kitamura K; Arai K; Matsuda K; Sanada T; Urabe T; Inamura K; Kagaya T; Mizuno H; Fuchizaki U; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Kaneko S
PLoS One; 2017; 12(11):e0188549. PubMed ID: 29166415
[TBL] [Abstract][Full Text] [Related]
26. Azathioprine Maintenance Therapy to Prevent Relapses in Autoimmune Pancreatitis.
de Pretis N; Amodio A; Bernardoni L; Campagnola P; Capuano F; Chari ST; Crinò S; Gabbrielli A; Massella A; Topazian M; Frulloni L
Clin Transl Gastroenterol; 2017 Apr; 8(4):e90. PubMed ID: 28448071
[TBL] [Abstract][Full Text] [Related]
27. Outcome and Genetic Factors in IgG4-Associated Autoimmune Pancreatitis and Cholangitis: A Single Center Experience.
Buechter M; Manka P; Heinemann FM; Lindemann M; Juntermanns B; Canbay A; Gerken G; Kahraman A
Gastroenterol Res Pract; 2017; 2017():6126707. PubMed ID: 28348580
[No Abstract] [Full Text] [Related]
28. Long-term outcomes of autoimmune pancreatitis.
Ikeura T; Miyoshi H; Shimatani M; Uchida K; Takaoka M; Okazaki K
World J Gastroenterol; 2016 Sep; 22(34):7760-6. PubMed ID: 27678359
[TBL] [Abstract][Full Text] [Related]
29. Autoimmune pancreatitis.
Omiyale AO
Gland Surg; 2016 Jun; 5(3):318-26. PubMed ID: 27294040
[TBL] [Abstract][Full Text] [Related]
30. A Patient with Autoimmune Pancreatitis Type 1 with Previously Known Lymphadenopathy, Both in the Context of IgG4-related Disease.
Alidjan FM; Karim F; Verdijk RM; van Esser JW; van Heerde MJ
Am J Case Rep; 2015 Nov; 16():790-3. PubMed ID: 26537530
[TBL] [Abstract][Full Text] [Related]
31. Review of diagnostic criteria for autoimmune pancreatitis; for establishment of international criteria.
Nishimori I; Onishi S; Otsuki M
Clin J Gastroenterol; 2008 Apr; 1(1):7-17. PubMed ID: 26193354
[TBL] [Abstract][Full Text] [Related]
32. Autoimmune pancreatitis associated with a large pancreatic pseudocyst that disappeared after corticosteroid therapy: a case report and literature review.
Nishimura N; Tamada K; Wada S; Ohashi A; Hatanaka H; Nakazawa K; Numao N; Kitamura A; Satoh K; Yamamoto H; Sugano K
Clin J Gastroenterol; 2009 Jun; 2(3):199-203. PubMed ID: 26192296
[TBL] [Abstract][Full Text] [Related]
33. Autoimmune pancreatitis complicated by an infected pseudocyst.
Chang KA; Kim TN; Lee SH
Clin J Gastroenterol; 2010 Jun; 3(3):168-73. PubMed ID: 26190126
[TBL] [Abstract][Full Text] [Related]
34. Hepatopancreatobiliary manifestations of inflammatory bowel disease.
Nakamura K; Ito T; Kotoh K; Ihara E; Ogino H; Iwasa T; Tanaka Y; Iboshi Y; Takayanagi R
Clin J Gastroenterol; 2012 Feb; 5(1):1-8. PubMed ID: 26181867
[TBL] [Abstract][Full Text] [Related]
35. Autoimmune pancreatitis can develop into chronic pancreatitis.
Maruyama M; Watanabe T; Kanai K; Oguchi T; Asano J; Ito T; Ozaki Y; Muraki T; Hamano H; Arakura N; Kawa S
Orphanet J Rare Dis; 2014 May; 9():77. PubMed ID: 24884922
[TBL] [Abstract][Full Text] [Related]
36. Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 III. Treatment and prognosis of autoimmune pancreatitis.
Kamisawa T; Okazaki K; Kawa S; Ito T; Inui K; Irie H; Nishino T; Notohara K; Nishimori I; Tanaka S; Nishiyama T; Suda K; Shiratori K; Tanaka M; Shimosegawa T;
J Gastroenterol; 2014 Jun; 49(6):961-70. PubMed ID: 24639058
[TBL] [Abstract][Full Text] [Related]
37. Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 I. Concept and diagnosis of autoimmune pancreatitis.
Okazaki K; Kawa S; Kamisawa T; Ito T; Inui K; Irie H; Nishino T; Notohara K; Nishimori I; Tanaka S; Nishiyama T; Suda K; Shiratori K; Tanaka M; Shimosegawa T;
J Gastroenterol; 2014 Apr; 49(4):567-88. PubMed ID: 24639057
[TBL] [Abstract][Full Text] [Related]
38. Should Steroid Therapy Be Necessarily Needed for Autoimmune Pancreatitis Patients with Lesion Resected due to Misdiagnosed or Suspected Malignancy?
Wu W; Yao X; Lin C; Jin D; Wang D; Lou W; Qin X
Gastroenterol Res Pract; 2014; 2014():253471. PubMed ID: 24578705
[TBL] [Abstract][Full Text] [Related]
39. IgG4-related Disease: 2013 Update.
Monach PA
Curr Treat Options Cardiovasc Med; 2013 Apr; 15(2):214-23. PubMed ID: 23392964
[TBL] [Abstract][Full Text] [Related]
40. Retroperitoneal fibrosis associated with immunoglobulin G4-related disease.
Fujimori N; Ito T; Igarashi H; Oono T; Nakamura T; Niina Y; Hijioka M; Lee L; Uchida M; Takayanagi R
World J Gastroenterol; 2013 Jan; 19(1):35-41. PubMed ID: 23326160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
